News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,038 Results
Type
Article (20032)
Company Profile (128)
Press Release (313878)
Section
Business (105592)
Career Advice (879)
Deals (18565)
Drug Delivery (97)
Drug Development (50967)
Employer Resources (79)
FDA (7708)
Job Trends (7754)
News (186342)
Policy (17381)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (740)
Accelerated approval (3)
Adcomms (17)
Allergies (40)
Alliances (27915)
ALS (53)
Alzheimer's disease (633)
Antibody-drug conjugate (ADC) (89)
Approvals (7722)
Artificial intelligence (136)
Autoimmune disease (12)
Automation (4)
Bankruptcy (177)
Best Places to Work (5562)
BIOSECURE Act (13)
Biosimilars (94)
Biotechnology (57)
Bladder cancer (30)
Brain cancer (18)
Breast cancer (104)
Cancer (1021)
Cardiovascular disease (109)
Career advice (712)
Career pathing (20)
CAR-T (54)
Cell therapy (149)
Cervical cancer (5)
Clinical research (42786)
Collaboration (450)
Compensation (153)
Complete response letters (23)
COVID-19 (1102)
CRISPR (21)
C-suite (143)
Cystic fibrosis (56)
Data (1081)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (137)
Diagnostics (1821)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (75)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (59)
Earnings (39058)
Editorial (30)
Employer branding (10)
Employer resources (73)
Events (48747)
Executive appointments (420)
FDA (8275)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (304)
Gene editing (46)
Generative AI (17)
Gene therapy (143)
GLP-1 (579)
Government (1840)
Grass and pollen (2)
Guidances (18)
Healthcare (5938)
Huntington's disease (13)
IgA nephropathy (20)
Immunology and inflammation (79)
Indications (17)
Infectious disease (1180)
Inflammatory bowel disease (83)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (53)
Interviews (116)
IPO (7384)
IRA (45)
Job creations (2433)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (276)
Leadership (14)
Legal (4120)
Liver cancer (31)
Lung cancer (156)
Lymphoma (83)
Machine learning (2)
Management (30)
Manufacturing (191)
MASH (47)
Medical device (1992)
Medtech (1995)
Mergers & acquisitions (11421)
Metabolic disorders (474)
Multiple sclerosis (48)
NASH (20)
Neurodegenerative disease (46)
Neuropsychiatric disorders (20)
Neuroscience (933)
NextGen: Class of 2025 (2363)
Non-profit (907)
Northern California (1045)
Now hiring (20)
Obesity (296)
Opinion (189)
Ovarian cancer (33)
Pain (65)
Pancreatic cancer (35)
Parkinson's disease (82)
Partnered (11)
Patents (130)
Patient recruitment (45)
Peanut (16)
People (33429)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13427)
Phase II (18096)
Phase III (14524)
Pipeline (683)
Podcasts (69)
Policy (104)
Postmarket research (1618)
Preclinical (4663)
Press Release (30)
Prostate cancer (58)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (233)
Real estate (3197)
Recruiting (29)
Regulatory (12550)
Reports (22)
Research institute (820)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (24)
Schizophrenia (58)
Series A (56)
Series B (32)
Service/supplier (6)
Sickle cell disease (35)
Southern California (1008)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2012)
State (2)
Stomach cancer (9)
Supply chain (49)
Tariffs (14)
The Weekly (49)
United States (9825)
Vaccines (267)
Venture capitalists (27)
Webinars (11)
Weight loss (233)
Women's health (14)
Worklife (7)
Date
Today (29)
Last 7 days (354)
Last 30 days (1380)
Last 365 days (17032)
2025 (4354)
2024 (17730)
2023 (19790)
2022 (26033)
2021 (26806)
2020 (24980)
2019 (20094)
2018 (15637)
2017 (17308)
2016 (16229)
2015 (18833)
2014 (14801)
2013 (12554)
2012 (13496)
2011 (13825)
2010 (12756)
Location
Africa (410)
Alabama (22)
Alaska (1)
Arizona (64)
Arkansas (8)
Asia (25571)
Australia (3215)
California (2447)
Canada (1070)
China (338)
Colorado (95)
Connecticut (96)
Delaware (68)
Europe (51370)
Florida (420)
Georgia (53)
Idaho (16)
Illinois (238)
India (19)
Indiana (169)
Iowa (3)
Japan (111)
Kansas (61)
Kentucky (17)
Louisiana (2)
Maine (4)
Maryland (372)
Massachusetts (2062)
Michigan (46)
Minnesota (135)
Mississippi (1)
Missouri (27)
Montana (10)
Nebraska (11)
Nevada (15)
New Hampshire (8)
New Jersey (996)
New Mexico (21)
New York (717)
North Carolina (488)
North Dakota (2)
Northern California (1045)
Ohio (80)
Oklahoma (5)
Oregon (21)
Pennsylvania (573)
Puerto Rico (10)
Rhode Island (14)
South America (606)
South Carolina (3)
Southern California (1008)
Tennessee (38)
Texas (323)
Utah (53)
Virginia (79)
Washington D.C. (41)
Washington State (209)
Wisconsin (19)
334,038 Results for "suzhou kintor pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Study of Kintor’s c-Myc Degrader Published in Subsidiary Journal of Nature
Kintor Pharmaceutical Limited announces that Kintor and its cooperative partner had published an article named MYC Induces CDK4/6 Inhibitors Resistance by Promoting pRB1 Degradation in a subsidiary journal of Nature—Nature Communications.
March 13, 2024
·
2 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China
Kintor Pharmaceutical Limited announced that its Hedgehog/SMO inhibitor GT1708F had obtained conditional approval to conduct Phase II clinical trial in China by the National Medical Products Administration for treatment of idiopathic pulmonary fibrosis.
October 11, 2023
·
2 min read
Business
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress
Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended 31 December 2022.
March 30, 2023
·
8 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Drug Development
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the Phase II clinical trial of in-house developed KX-826 for the treatment of male androgenetic alopecia (“AGA”) in the US has been completed successfully.
May 11, 2023
·
3 min read
Drug Development
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
Kintor Pharmaceutical Limited announced that the company has completed the enrollment of 180 patients for the Phase II clinical trial of its in-house developed first-in-class proteolysis targeting chimera compound GT20029 in China for the treatment of male androgenetic alopecia.
August 22, 2023
·
2 min read
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China
October 30, 2024
·
2 min read
Drug Development
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China
Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939) announced that the company has completed the enrollment of 740 subjects recently for the Phase III clinical trial of its in-house developed first-in-class drug candidate KX-826 (pyrilutamide) in China for the treatment of male androgenetic alopecia (AGA) adults.
March 28, 2023
·
4 min read
1 of 33,404
Next